Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01084577
Other study ID # CW-0142-09-U354
Secondary ID
Status Completed
Phase Phase 4
First received March 9, 2010
Last updated February 17, 2011
Start date January 2010
Est. completion date January 2011

Study information

Verified date February 2011
Source ConvaTec Inc.
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics CommitteeFrance: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)Poland: Ethics CommitteeGermany: Ethics CommissionDenmark: Ethics Committee
Study type Interventional

Clinical Trial Summary

A prospective, comparative, randomised study to compare the effects on ulcer healing of AQUACEL® Ag dressing when used for 4 weeks followed by treatment with AQUACEL® for 4 weeks to Urgotul® Silver dressing followed by Urgotul® for 4 weeks on subjects with venous leg ulcers.


Recruitment information / eligibility

Status Completed
Enrollment 266
Est. completion date January 2011
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects over 18 years, willing and able to provide written informed consent.

- Subjects who have an ankle to brachial pressure index (ABPI) of 0.8 or greater.

- Subjects who have a venous leg ulcer (i.e. CEAP classification of C6), with duration less than 24 months and size ranging between 5 cm2-40 cm2 .

- Subjects' leg ulcers will meet at least 3 of the 5 following clinical signs: pain between 2 dressing changes, perilesional skin erythema, oedema, foul odour, and heavy exudation.

- Subjects agree to wear compression therapy daily in combination with the trial dressing.

Exclusion Criteria:

- Subjects with a history of skin sensitivity to any of the components of the study product.

- Subjects who have had current local or systemic antibiotics in the week prior to inclusion.

- Subjects whose leg ulcers are clinically infected or erysipelas, malignant, or who have had recent deep venous thrombosis or venous surgery within the last 3 months.

- Subjects who have a progressive neoplastic lesion treated by radiotherapy or chemotherapy, or on-going treatment with immunosuppressive agents or high dose corticosteroids.

- Subjects who have participated in a clinical study within the past 3 months.

- Subjects who are pregnant or breastfeeding (in accordance with the Urgotul® Silver package insert).

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
AQUACEL® Ag
AQUACEL® Ag dressing for four weeks followed by AQUACEL® for the remaining 4 weeks.
Urgotul® Silver
Urgotul® Silver for four weeks followed by Urgotul® for the remaining 4 weeks.

Locations

Country Name City State
Denmark Arhus Universitets Hospital (#47) Arhus
Denmark Bispebjerg Universitets Hospital (#45) Copenhagen
Denmark Odense Universitets Hospital (#46) Odense
France 37 Bd Bury (#42) Angouleme
France CH de La Fere, (#44) La Fere
France Clinique des Augustines (#38) Malestroit
France 19 rue des Clers (#37) Metz
France (#35) Paris Neuilly sur Siene
France Centre de Sante (#36) Paris
France Hopital Brocca, 54/56 rue Pascal (#41) Paris
France Clinique Pasteur (#40) Toulouse
Germany Chirurgisches Zentrum Bethanien (#34) Frankfurt/Main Usinger Str 5
Germany Hautarztpraxis Dr Klovekorn (#33) Gilching Romerstr 4
Germany Arztin fur Allgemeinmedizin (#30) Munchen
Germany Praxis Dr Thinesse-Mallwitz (#31) Munchen Faustlestr 3
Poland Szpital Woj.w Bielsku-Bialej (#61) Bielsko-Biala ul.Armii Krajowej 101
Poland Poradnia Chirurgiczna Szpital, Specjalistyczny nr.2 (#50) Bytom ul.Batorego 15
Poland Centr. Med. Beluga-Med, NZOZ (#53) Krakow ul. Obopolna 4a
Poland Nzoz Certus (#64) Lodz ul.Kopernika 67-69
Poland Poradnia Chorob MIKOMED (#55) Lodz ul. Plugowa 51/53
Poland Nzoz Serce Sercu (#62) Mogilany ul.Sw.Bartlomieja Apostola 21
Poland Centr. Diagnostyki Ginek.-Poloz. (#51) Opole ul.1-go Maja 9/69-73
Poland Poradnia Medycyny Paliatywnej, Hospicjum Palium, SK im. Przemienienia Panskiego nr.1(#49) Poznan Os. Rusa 25a
Poland Venavita (#63) Poznan ul.Kurpiowska 8/5
Poland SPZOZ nr.1 Przyszpitalna Por. (#58) Rzeszow ul.Rycerska 4
Poland NZOZ Por. Chrurgiczna (#52) Strzelce Opolskie ul. Powstancow Slaskich 9
Poland SPZOZ UM w Lodzi (#54) ul. Narutowicza 96 Lodz
Poland CF Centrum Flebologii (#60) Warszawa ul.Witosynskiego 5
Poland NZoZ SEP-MED (#59) Warszawa ul. Hoza 19
Poland Specjal.Pomoc Med.MEDSERVICE (#56) Zabrze ul.M.Sklodowskiej-Curie 34
United Kingdom Distric Nurses, The Wilson Practice, Alton Health Centre (#9) Alton Hampshire
United Kingdom St Mary's Hospital (#7) Armley Leeds
United Kingdom City Hospital (#12) Birmingham West Midlands
United Kingdom Chalfont and Gerrards Cross Hospital (#14) Chalfont St Peter Buckinghamshire
United Kingdom Hainult Health Centre (#24) Chigwell Essex
United Kingdom University Hospital (#15) Coventry West Midlands
United Kingdom Cross Street Health Centre (#4) Dudley West Midlands
United Kingdom Tissue Viability Consultancy (#3) Eastbourne
United Kingdom Forest Primary Care Center (#18) Edmonton London
United Kingdom Fareham College Specialist Leg Care Centre (#13) Fareham Hampshire
United Kingdom Tissue Viability Service NHS Harrow PCT (#26) Harrow Middlesex
United Kingdom Wound Healing Research Unit (#1) Heath Park Cardiff
United Kingdom Royal Free Hospital (#23) London
United Kingdom Vestry Close Health Clinic (#8) Luton Bedfordshire
United Kingdom Norwich Community Hospital (#21) Norwich Norfolk
United Kingdom Neath Port Talbot Hospital (#17) Port Talbot West Glamorgan
United Kingdom Rayleigh Clinic (#19) Rayleigh Essex
United Kingdom Solihull Hospital (#5) Solihull West Midlands
United Kingdom Southampton Hospital (#6) Southampton Hampshire
United Kingdom Mayday University Hospital Wound Clinic (#10) Thornton Health Surrey
United Kingdom Arrowe Park Hospital (#2) Upton Wirral
United Kingdom Tissue Viability Service, The Willows, Centre for Health Care (#11) Weaste Salford
United Kingdom University Hopital (#15) West Midlands Coventry
United Kingdom Southend University Hopital (#20) Westcliff-on-Sea Essex
United Kingdom Goldsworth Park Health Centre (022) Woking Surrey
United Kingdom Stourport Health Centre (#16) Worcestershire

Sponsors (1)

Lead Sponsor Collaborator
ConvaTec Inc.

Countries where clinical trial is conducted

Denmark,  France,  Germany,  Poland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wound area reduction from baseline (relative) 8 weeks No
Secondary Wound closure 8 weeks No
Secondary Clinical evolution of the wound presence of each of the 5 selected clinical signs 8 weeks No
Secondary Tolerance occurrence of local adverse events 8 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03644849 - Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing N/A
Recruiting NCT02842502 - Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Case of Chronic Leg Ulcers N/A
Active, not recruiting NCT01903044 - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating Phase 1/Phase 2
Terminated NCT01966380 - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia Phase 2
Terminated NCT02509533 - Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method N/A
Completed NCT00371371 - Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) Phase 1/Phase 2
Active, not recruiting NCT00270972 - The Evaluation of OrCel for the Treatment of Venous Ulcers N/A
Terminated NCT01657318 - Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Completed NCT02392390 - Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds N/A
Not yet recruiting NCT06007703 - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Recruiting NCT02987101 - Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction N/A
Active, not recruiting NCT02973893 - Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Phase 2
Not yet recruiting NCT02873728 - Remote Ischemic Conditioning for Treatment of Chronic Wounds N/A
Completed NCT01551667 - Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds N/A
Completed NCT01497210 - EASH Dressing on Chronic Venous Leg Ulcers Phase 2
Completed NCT00235209 - A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers Phase 4
Not yet recruiting NCT06153589 - Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care N/A
Completed NCT01591434 - Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers Phase 3
Completed NCT00838500 - THERMES ET VEINES: Spa for Prevention of Leg Ulcers Phase 3
Completed NCT00243620 - A Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings N/A